Prognostic Role of Gestational Age and Birth Weight in Nephrotic Syndrome: A Retrospective Cross-Sectional Study
Journal of Pediatric Nephrology,
Vol. 9 No. 3 (2021),
Background and Aim: Nephrotic syndrome (NS) is a common disease in children characterized by proteinuria, hypoalbunemia and hyperlipidemia. In some cases, NS is resistant to steroid therapy and may have frequent relapses. The aim of this study was to determine the prognostic role of gestational age and birth weight in the clinical outcomes of NS.
Methods: This retrospective cross-sectional study was conducted on 77 patients. The patients’ data such as history of relapse and steroid resistance, birth weight, gestational age, and pathological variant were collected. Data was analysed using the SPSS software.
Results: Twenty-three patients were females and 54 were males. There was no significant association between the number of recurrences and premature birth (P value= 0.99). Mann-Whitney U test showed no significant difference between birth weight of patients who recurred less than two times during six months and those who recurred more than two times in six months (P= 0.336). Besides, Fisher’s exact test showed no significant association between premature birth and the chance of developing steroid resistance (P value = 0.643). Moreover, there was no significant association between birth weight and steroid resistance (P-value = 0.768).
Conclusion: Low birth weight and premature birth did not have a role in the prognosis of nephrotic syndrome in our study population. Other factors including uterine-placental disorders, maternal underlying diseases, quality of weight gain in the first years of life, and ethnicity should also be examined in further investigations including larger samples of different ethnic groups.
- Nephrotic Syndrome
- Streoid Resistance
- Gestational Age
- Low Birth Weight
How to Cite
Bagga A, Mantan M. Nephrotic syndrome in children. Indian Journal of medical research. 2005;122(1):13.
Leung AK, Wong AH. Proteinuria in children. American family physician. 2010;82(6):645-51.
Leung AK, Wong AH, Barg SS. Proteinuria in children: evaluation and differential diagnosis. American family physician. 2017;95(4):248-54.
Bergstein JM. A practical approach to proteinuria. Pediatric Nephrology. 1999;13(8):697-700.
Noone DG, Iijima K, Parekh R. Idiopathic nephrotic syndrome in children. The Lancet. 2018;392(10141):61-74.
WEI CC, YU IW, LIN HW, Tsai AC. Occurrence of infection among children with nephrotic syndrome during hospitalizations. Nephrology. 2012;17(8):681-8.
Park SJ, Shin JI. Complications of nephrotic syndrome. Korean journal of pediatrics. 2011;54(8):322.
Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Nephrology Dialysis Transplantation. 2005;20(8):1598-603.
Hampson KJ, Gay ML, Band ME. Pediatric Nephrotic Syndrome: Pharmacologic and Nutrition Management. Nutrition in Clinical Practice. 2021.
Hahn D, Hodson EM, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane database of systematic reviews. 2015(3).
Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, Pisano L. Urinary excretion of IgG and [alpha] 1-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. American journal of kidney diseases. 2001;38(2):240-8.
Wu HM, Tang JL, Cao L, Sha ZH, Li Y. Interventions for preventing infection in nephrotic syndrome. Cochrane Database of Systematic Reviews. 2012(4).
Büscher AK, Kranz B, Büscher R, Hildebrandt F, Dworniczak B, Pennekamp P, et al. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clinical Journal of the American Society of Nephrology. 2010;5(11):2075-84.
Munyentwali H, Bouachi K, Audard V, Remy P, Lang P, Mojaat R, et al. Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease. Kidney international. 2013;83(3):511-6.
Ozeki T, Ando M, Yamaguchi M, Katsuno T, Kato S, Yasuda Y, et al. Treatment patterns and steroid dose for adult minimal change disease relapses: A retrospective cohort study. PloS one. 2018;13(6):e0199228.
Rezavand N, Seyedzadeh A, Tohidi M-R, Seyedzadeh M-S, Hookary S, Abdi A. The relationship between low-birth weight and nephrotic syndrome in children. Journal of Nephropharmacology. 2017;7(1):6-9.
Plank C, Östreicher I, Dittrich K, Waldherr R, Voigt M, Amann K, et al. Low birth weight, but not postnatal weight gain, aggravates the course of nephrotic syndrome. Pediatric Nephrology. 2007;22(11):1881-9.
Konstantelos N, Banh T, Patel V, Vasilevska-Ristovska J, Borges K, Hussain-Shamsy N, et al. Association of low birth weight and prematurity with clinical outcomes of childhood nephrotic syndrome: a prospective cohort study. Pediatric Nephrology. 2019;34(9):1599-605.
Teeninga N, Schreuder MF, Bökenkamp A, Waal HAD-vd, Wijk JAv. Influence of low birth weight on minimal change nephrotic syndrome in children, including a meta-analysis. Nephrology Dialysis Transplantation. 2008;23(5):1615-20.
Wang J-J, Mao J-H. The etiology of congenital nephrotic syndrome: current status and challenges. World Journal of Pediatrics. 2016;12(2):149-58.
Ikezumi Y, Suzuki T, Karasawa T, Yamada T, Hasegawa H, Nishimura H, et al. Low birthweight and premature birth are risk factors for podocytopenia and focal segmental glomerulosclerosis. American journal of nephrology. 2013;38(2):149-57.
- Abstract Viewed: 89 times
- PDF Downloaded: 51 times